Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New turkish dizziness tool could improve diagnosis

NCT ID NCT07468864

Knowledge-focused Sponsor: Istanbul Medipol University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to translate and test the Situational Vertigo Questionnaire (SVQ) in Turkish. The SVQ measures dizziness triggered by visual environments like supermarkets or driving. Researchers will check if the Turkish version is valid and reliable by comparing it with other dizziness scales. The goal is to give Turkish-speaking doctors a better way to assess and treat dizziness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide Turkish-speaking clinicians with a validated tool to better evaluate and manage dizziness triggered by visual environments.
What could go wrong
This is a small, early-stage adaptation study with only 3 participants planned, so results may not be generalizable. The questionnaire's accuracy depends on cultural and linguistic factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Frequent complaints of dizziness and imbalance in vestibular pathologies are significant clinical problems that negatively affect individuals' daily life activities, social participation, and quality of life. In particular, valid and reliable measurement tools reflecting the individual's subjective experience are needed in the evaluation of situational dizziness symptoms triggered by visual or environmental stimuli. In this context, the Situational Vertigo Questionnaire (SVQ), widely used in the international literature, stands out as an important tool in the evaluation of dizziness symptoms associated with situational and visual stimuli.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Presence of dizziness triggered by visual or environmental stimuli * Able to read and write Turkish * Voluntary agreement to participate in the study * Having the mental capacity to give informed consent (Mini Mental State Scale score ≥ 24) Exclusion Criteria: * Individuals with severe cognitive impairment or communication difficulties * Acute neurological disease (stroke, acute MS relapse, etc.) * Having undergone vestibular surgery within the last 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vestibular pathology are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

vestibular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vestibular pathology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Güneşli Erdem Hastanesi

    RECRUITING

    Bağcılar, Güneşli, 34200, Turkey (Türkiye)